These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29885044)

  • 61. Continuous glucose monitoring to evaluate glycaemic abnormalities in cystic fibrosis.
    Zorrón Mei Hsia Pu M; Gonçalves AC; Minnicucci WJ; Morcillo AM; Ribeiro JD; Ribeiro AF
    Arch Dis Child; 2018 Jun; 103(6):592-596. PubMed ID: 29378680
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcome of cystic fibrosis-related diabetes two years after lung transplantation.
    Valour F; Brault C; Abbas-Chorfa F; Martin C; Kessler L; Kanaan R; Mosnier-Pudar H; Coltey B; Nove-Josserand R; Durupt S; Colin C; Durieu I
    Respiration; 2013; 86(1):32-8. PubMed ID: 22922226
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of hyperinsulinemia and insulin resistance on in vivo β-cell function: their role in human β-cell dysfunction.
    Mari A; Tura A; Natali A; Anderwald C; Balkau B; Lalic N; Walker M; Ferrannini E;
    Diabetes; 2011 Dec; 60(12):3141-7. PubMed ID: 22028180
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Beta-cell function and glucose metabolism in patients with chronic pancreatitis.
    Ciccarelli G; Di Giuseppe G; Soldovieri L; Quero G; Nista EC; Brunetti M; Cinti F; Moffa S; Capece U; Tondolo V; Mari A; Gasbarrini A; Pontecorvi A; Alfieri S; Giaccari A; Mezza T
    Eur J Intern Med; 2024 Jun; ():. PubMed ID: 38871564
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese.
    Mitsui R; Fukushima M; Taniguchi A; Nakai Y; Aoyama S; Takahashi Y; Tsuji H; Yabe D; Yasuda K; Kurose T; Kawakita T; Seino Y; Inagaki N
    J Diabetes Investig; 2012 Aug; 3(4):377-83. PubMed ID: 24843593
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proinsulin is sensitive to reflect glucose intolerance.
    Nakamura A; Miyoshi H; Ukawa S; Nakamura K; Nakagawa T; Terauchi Y; Tamakoshi A; Atsumi T
    J Diabetes Investig; 2020 Jan; 11(1):75-79. PubMed ID: 31222973
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes.
    Mannik LA; Chang KA; Annoh PQK; Sykes J; Gilmour J; Robert R; Stephenson AL
    J Cyst Fibros; 2018 Jul; 17(4):536-541. PubMed ID: 29680365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Burned Adults Develop Profound Glucose Intolerance.
    Rehou S; Mason S; Burnett M; Jeschke MG
    Crit Care Med; 2016 Jun; 44(6):1059-66. PubMed ID: 26934145
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proinsulin-to-C-Peptide Ratio as a Marker of β-Cell Function in African American and European American Adults.
    Couch CA; Piccinini F; Fowler LA; Garvey WT; Gower BA
    Diabetes Care; 2023 Dec; 46(12):2129-2136. PubMed ID: 36787895
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Loss-of-function mutations in ABCA1 and enhanced β-cell secretory capacity in young adults.
    Rickels MR; Goeser ES; Fuller C; Lord C; Bowler AM; Doliba NM; Hegele RA; Cuchel M
    Diabetes; 2015 Jan; 64(1):193-9. PubMed ID: 25125487
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
    Rakotoarisoa L; Weiss L; Lefebvre F; Porzio M; Renaud-Picard B; Ravoninjatovo B; Abely M; Danner-Boucher I; Dubois S; Troussier F; Prevotat A; Rault G; Kessler R; Kessler L
    J Diabetes Complications; 2024 Apr; 38(4):108703. PubMed ID: 38430625
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevation of one hour plasma glucose during oral glucose tolerance testing.
    Sheikh S; Putt ME; Forde KA; Rubenstein RC; Kelly A
    Pediatr Pulmonol; 2015 Oct; 50(10):963-9. PubMed ID: 26087115
    [TBL] [Abstract][Full Text] [Related]  

  • 73. {beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants.
    Rickels MR; Mueller R; Teff KL; Naji A
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1238-46. PubMed ID: 20097708
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vitamin D and 1-hour post-load plasma glucose in hypertensive patients.
    Sciacqua A; Perticone M; Grillo N; Falbo T; Bencardino G; Angotti E; Arturi F; Parlato G; Sesti G; Perticone F
    Cardiovasc Diabetol; 2014 Feb; 13():48. PubMed ID: 24555478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.
    Olivier AK; Yi Y; Sun X; Sui H; Liang B; Hu S; Xie W; Fisher JT; Keiser NW; Lei D; Zhou W; Yan Z; Li G; Evans TI; Meyerholz DK; Wang K; Stewart ZA; Norris AW; Engelhardt JF
    J Clin Invest; 2012 Oct; 122(10):3755-68. PubMed ID: 22996690
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Indexes of β-cell function from the oral glucose tolerance test can modestly predict pancreatic β-cell area in Korean.
    Kim SK; Kim JH; Park JY; No HS; Jang KT; Heo JS; Choi SH; Choi DW; Kim KW
    Diabetes Res Clin Pract; 2011 Aug; 93(2):220-227. PubMed ID: 21612838
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lack of correlation between 1,5-anhydroglucitol assay and oral glucose tolerance test in patients with cystic fibrosis.
    Kinnaird KE; Sauerwein TJ
    Endocr Pract; 2010; 16(2):167-70. PubMed ID: 19833588
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intestinal Glucose Absorption Is a Key Determinant of 1-Hour Postload Plasma Glucose Levels in Nondiabetic Subjects.
    Tricò D; Mengozzi A; Frascerra S; Scozzaro MT; Mari A; Natali A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2131-2139. PubMed ID: 30445459
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosis.
    Battezzati A; Foppiani A; Alicandro G; Bisogno A; Biffi A; Bedogni G; Bertoli S; De Carlo G; Nazzari E; Colombo C
    Endocr Connect; 2022 May; 11(5):. PubMed ID: 35358060
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.